Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $641,940 |
Sells | 126 | $5,108,688 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 21 | 14 | 294 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 25 | 14 | 350 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 46 | 14.03 | 645 | D |
06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 59 | 14.0069 | 826 | D |
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 68 | 16.82 | 1,144 | D |
19 Sep 2022 16:34 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 15 Sep 2022 | Sale | 100 | 15.01 | 1,501 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 26 Dec 2023 | Sale | 94 | 16.67 | 1,567 | D |
19 Sep 2022 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 15 Sep 2022 | Sale | 106 | 15.0134 | 1,591 | D |
03 Mar 2023 16:37 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Mar 2023 | Sale | 145 | 11.2282 | 1,628 | D |
03 Mar 2023 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Mar 2023 | Sale | 164 | 11.2227 | 1,841 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 31 Aug 2022 | Sale | 171 | 12 | 2,052 | D |
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 25 Oct 2022 | Sale | 100 | 22.13 | 2,213 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 30 Aug 2022 | Sale | 190 | 12 | 2,280 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 18 Aug 2022 | Sale | 200 | 13 | 2,600 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 16 Aug 2022 | Sale | 200 | 13 | 2,600 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 17 Aug 2022 | Sale | 200 | 13.07 | 2,614 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Aug 2022 | Sale | 217 | 13.0047 | 2,822 | D |
19 Sep 2022 16:35 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 15 Sep 2022 | Sale | 200 | 15.04 | 3,008 | D |
29 Mar 2023 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Mar 2023 | Sale | 200 | 15.51 | 3,102 | D |
28 Sep 2022 17:08 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 26 Sep 2022 | Sale | 215 | 16.2477 | 3,493 | D |
06 Dec 2022 17:02 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 05 Dec 2022 | Sale | 200 | 18.05 | 3,610 | D |
18 Nov 2022 16:59 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 16 Nov 2022 | Sale | 200 | 18.1 | 3,620 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 24 Aug 2022 | Sale | 301 | 14.227 | 4,282 | D |
28 Sep 2022 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 26 Sep 2022 | Sale | 288 | 16.3028 | 4,695 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Sep 2022 | Sale | 300 | 16.33 | 4,899 | D |
29 Dec 2022 16:51 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Dec 2022 | Sale | 400 | 15.0128 | 6,005 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 505 | 13.5097 | 6,822 | D |
29 Dec 2022 16:51 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Dec 2022 | Sale | 600 | 14.7989 | 8,879 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 21 Mar 2024 | Purchase | 704 | 13.2353 | 9,318 | D |
12 Sep 2022 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 09 Sep 2022 | Sale | 688 | 15.0669 | 10,366 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 19 Mar 2024 | Purchase | 900 | 12.6633 | 11,397 | D |
06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 871 | 13.4647 | 11,728 | D |
12 Sep 2022 16:18 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 09 Sep 2022 | Sale | 800 | 15.0669 | 12,054 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 904 | 13.4522 | 12,161 | D |
06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 913 | 13.4312 | 12,263 | D |
12 Sep 2022 16:14 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 09 Sep 2022 | Sale | 865 | 15.0646 | 13,031 | D |
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Oct 2022 | Sale | 643 | 21.2104 | 13,638 | D |
12 Sep 2022 16:14 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 08 Sep 2022 | Sale | 912 | 15.1472 | 13,814 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 1,109 | 12.5615 | 13,931 | D |
23 Sep 2022 16:57 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 23 Sep 2022 | Sale | 939 | 15.0871 | 14,167 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 20 Mar 2024 | Purchase | 1,128 | 12.6604 | 14,281 | D |
24 Oct 2022 17:10 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 20 Oct 2022 | Sale | 811 | 18.0113 | 14,607 | D |
20 Feb 2024 16:37 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 15 Feb 2024 | Sale | 1,000 | 15 | 15,000 | D |
22 Dec 2023 16:38 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 20 Dec 2023 | Sale | 1,000 | 15 | 15,000 | D |
19 Oct 2023 17:27 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 17 Oct 2023 | Sale | 1,000 | 15 | 15,000 | D |
15 Sep 2023 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 13 Sep 2023 | Sale | 1,000 | 15 | 15,000 | D |
20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 16 May 2024 | Sale | 1,000 | 15 | 15,000 | D |
28 Sep 2022 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Sep 2022 | Sale | 966 | 15.824 | 15,286 | D |
23 Sep 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 23 Sep 2022 | Sale | 1,018 | 15.0694 | 15,341 | D |
23 Sep 2022 16:59 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 23 Sep 2022 | Sale | 1,023 | 15.066 | 15,413 | D |
03 Mar 2023 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Mar 2023 | Sale | 1,477 | 10.4912 | 15,496 | D |
16 Aug 2023 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 14 Aug 2023 | Sale | 1,000 | 15.6713 | 15,671 | D |
18 Jan 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 16 Jan 2024 | Sale | 1,000 | 15.99 | 15,990 | D |
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 1,000 | 16.0117 | 16,012 | D |
14 Jun 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 13 Jun 2024 | Sale | 1,000 | 16.1736 | 16,174 | D |
13 Nov 2023 16:35 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 13 Nov 2023 | Sale | 1,000 | 16.23 | 16,230 | D |
24 Oct 2022 17:13 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 20 Oct 2022 | Sale | 905 | 18.0735 | 16,357 | D |
12 Sep 2022 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 08 Sep 2022 | Sale | 1,100 | 15.1577 | 16,673 | D |
03 Mar 2023 16:37 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Mar 2023 | Sale | 1,602 | 10.4625 | 16,761 | D |
20 May 2024 17:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 17 May 2024 | Sale | 1,200 | 15.1076 | 18,129 | D |
12 Sep 2022 16:18 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 08 Sep 2022 | Sale | 1,221 | 15.1333 | 18,478 | D |
27 Oct 2022 18:48 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 25 Oct 2022 | Sale | 900 | 21.8544 | 19,669 | D |
28 Sep 2022 17:08 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 26 Sep 2022 | Sale | 1,329 | 15.32 | 20,360 | D |
01 Apr 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 28 Mar 2024 | Purchase | 1,512 | 13.7526 | 20,794 | D |
24 Oct 2022 17:13 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 24 Oct 2022 | Sale | 1,102 | 18.8809 | 20,807 | D |
24 Oct 2022 17:10 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 24 Oct 2022 | Sale | 1,101 | 18.8999 | 20,809 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 25 Aug 2022 | Sale | 1,551 | 14.1754 | 21,986 | D |
08 Mar 2024 16:34 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 06 Mar 2024 | Sale | 1,826 | 12.3213 | 22,499 | D |
02 Mar 2023 16:36 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 28 Feb 2023 | Sale | 2,000 | 12 | 24,000 | D |
29 Jul 2022 16:03 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Jul 2022 | Sale | 2,000 | 12 | 24,000 | D |
30 Jan 2023 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Jan 2023 | Sale | 2,000 | 12.0005 | 24,001 | D |
24 Oct 2022 17:10 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 24 Oct 2022 | Sale | 1,241 | 19.6456 | 24,380 | D |
24 Oct 2022 17:13 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 24 Oct 2022 | Sale | 1,302 | 19.6583 | 25,595 | D |
29 Mar 2023 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Mar 2023 | Sale | 1,800 | 14.6296 | 26,333 | D |
20 May 2024 17:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 16 May 2024 | Sale | 1,800 | 15 | 27,000 | D |
01 May 2023 16:38 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Apr 2023 | Sale | 2,000 | 13.7109 | 27,422 | D |
30 Nov 2022 16:31 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 28 Nov 2022 | Sale | 2,000 | 13.9131 | 27,826 | D |
10 May 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 09 May 2024 | Purchase | 2,200 | 14.2459 | 31,341 | D |
10 May 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 08 May 2024 | Purchase | 2,276 | 14.0442 | 31,965 | D |
27 Oct 2022 18:46 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 25 Oct 2022 | Sale | 1,500 | 21.5007 | 32,251 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Dec 2023 | Sale | 2,200 | 15.0703 | 33,155 | D |
10 Apr 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 08 Apr 2024 | Purchase | 2,600 | 13.573 | 35,290 | D |
10 Jan 2023 16:40 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 09 Jan 2023 | Sale | 2,410 | 15.0189 | 36,196 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 27 Sep 2022 | Sale | 2,403 | 15.3096 | 36,789 | D |
26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 26 Mar 2024 | Purchase | 2,750 | 13.6397 | 37,509 | D |
19 Apr 2023 18:07 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 17 Apr 2023 | Sale | 2,092 | 18.0092 | 37,675 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 23 Aug 2022 | Sale | 2,909 | 13.0903 | 38,080 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 24 Aug 2022 | Sale | 2,817 | 13.5226 | 38,093 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Sep 2022 | Sale | 2,768 | 15.2206 | 42,131 | D |
26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 25 Mar 2024 | Purchase | 3,180 | 13.356 | 42,472 | D |
28 Sep 2022 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 26 Sep 2022 | Sale | 2,795 | 15.2165 | 42,530 | D |
26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 22 Mar 2024 | Purchase | 3,118 | 13.759 | 42,901 | D |
27 Oct 2022 18:46 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Oct 2022 | Sale | 2,000 | 21.6625 | 43,325 | D |
28 Sep 2022 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 28 Sep 2022 | Sale | 3,085 | 15.2339 | 46,997 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 28 Sep 2022 | Sale | 3,122 | 15.2497 | 47,610 | D |
29 Jun 2022 16:02 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Jun 2022 | Sale | 4,000 | 12 | 48,000 | D |
23 Sep 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 21 Sep 2022 | Sale | 3,275 | 15.1258 | 49,537 | D |
08 Mar 2024 16:36 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Mar 2024 | Sale | 4,086 | 12.3067 | 50,285 | D |
23 Sep 2022 16:57 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 21 Sep 2022 | Sale | 3,341 | 15.0833 | 50,393 | D |
02 Nov 2022 16:54 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 31 Oct 2022 | Sale | 2,100 | 24.0453 | 50,495 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)